Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SDCBP | O00560 | 3/20 | 0.35 |
| ▸ | SDC2 | P34741 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.31 |
| ▸ | CHRNG | P07510 | 1/20 | 0.31 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.31 |
| ▸ | CHRND | Q07001 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18661756 | 1.00 | SDCBP (0.35) | SDCBPSDC2MAPTHSD17B10MEN1 | |
| SCHEMBL27431572 | 0.88 | HSD17B10 (0.37) | SDCBPSDC2MAPTHSD17B10MEN1 | |
| SCHEMBL18055663 | 0.88 | SDCBP (0.35) | SDCBPSDC2MAPTHSD17B10MEN1 | |
| SCHEMBL22154737 | 0.88 | SDCBP (0.35) | SDCBPSDC2MAPTHSD17B10MEN1 | |
| SCHEMBL21152279 | 0.85 | SDCBP (0.34) | SDCBPSDC2MAPTHSD17B10MEN1 | |
| SCHEMBL30748708 | 0.85 | SDCBP (0.34) | SDCBPSDC2MAPTHSD17B10MEN1 | |
| SCHEMBL29321549 | 0.84 | TSHR (0.38) | SDCBPSDC2MAPTHSD17B10MEN1 | |
| SCHEMBL24297441 | 0.84 | RXFP1 (0.35) | — | |
| SCHEMBL24297058 | 0.83 | CA1 (0.36) | HSD17B10MEN1KMT2A | |
| SCHEMBL26261230 | 0.82 | SMN1; SMN2 (0.35) | MEN1KMT2ACHRNA1CHRNGCHRNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040144-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2021-02-11 | — | — | US | disclosed |
| US-10711032-B2 | Steroids and protein-conjugates thereof | REGENERON PHARMACEUTICALS, INC. (US) | 2020-07-14 | — | — | US | disclosed |
| US-20180155389-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180155389-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | SERPINA6, NR3C1, NR3C2 | SDCBP 428/4885SDC2 2183/4885MAPT 3285/4885 |
| US-10711032-B2 | Steroids and protein-conjugates thereof | SERPINA6, NR3C1, NR3C2 | SDCBP 428/4885SDC2 2183/4885MAPT 3285/4885 |
| US-20210040144-A1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | SERPINA6, NR3C1, NR3C2 | SDCBP 431/4885SDC2 2253/4885MAPT 2999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.